Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (673)

Search Parameters:
Keywords = date of delivery

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 4382 KB  
Review
Cydonia oblonga: A Comprehensive Overview of Applications in Dermatology and Cosmetics
by Ana Adamovic, Marina Tomovic, Marijana Andjic, Jovana Dimitrijevic, Miona Glisic and Miljan Adamovic
Cosmetics 2025, 12(5), 187; https://doi.org/10.3390/cosmetics12050187 - 28 Aug 2025
Viewed by 187
Abstract
This review aims to provide a comprehensive overview of the botany, phytochemical composition, and dermatological effects of Cydonia oblonga (CO), with a particular focus on its therapeutic mechanisms across various skin conditions. Among the different parts of the plant, the fruit and peel [...] Read more.
This review aims to provide a comprehensive overview of the botany, phytochemical composition, and dermatological effects of Cydonia oblonga (CO), with a particular focus on its therapeutic mechanisms across various skin conditions. Among the different parts of the plant, the fruit and peel are especially rich in bioactive compounds, primarily polyphenols such as phenolic acids, anthocyanins, and flavonoids, which are known for their potent antioxidant activity. These constituents contribute significantly to the fruit and peel’s health-promoting properties. To date, multiple extracts derived from various CO parts have been studied in both in vitro and in vivo models. Reported dermatological effects include antioxidant, antimicrobial, anti-inflammatory, anti-allergic, UV-protective, moisturizing, and anti-aging effects, as well as beneficial outcomes in conditions such as wound healing, erythema, and hyperpigmentation. As a result, formulations containing CO-derived compounds have been developed for use in both diseased and healthy skin care. However, only a limited number of these effects have been validated in human clinical studies. Given the promising results from preclinical research, future directions should prioritize in vivo investigations in human subjects to determine optimal concentrations and delivery systems for targeting specific skin disorders. Full article
(This article belongs to the Section Cosmetic Dermatology)
Show Figures

Figure 1

41 pages, 1208 KB  
Review
Nano-Based Technology in Glioblastoma
by Dorota Bartusik-Aebisher, Izabela Rudy, Karolina Pięta and David Aebisher
Molecules 2025, 30(17), 3485; https://doi.org/10.3390/molecules30173485 - 25 Aug 2025
Viewed by 588
Abstract
Neoplasms of the central nervous system (CNS) constitute a minor fraction of all malignant tumors. CNS accounts for approximately 4% of newly diagnosed oncological cases. Among primary CNS neoplasms, gliomas predominate, comprising nearly 90% of all malignant brain tumors, with Glioblastoma (GBM) representing [...] Read more.
Neoplasms of the central nervous system (CNS) constitute a minor fraction of all malignant tumors. CNS accounts for approximately 4% of newly diagnosed oncological cases. Among primary CNS neoplasms, gliomas predominate, comprising nearly 90% of all malignant brain tumors, with Glioblastoma (GBM) representing the most prevalent and aggressive histological subtype. The earliest documented occurrences of GBM date back to the 19th century. Contemporary therapeutic modalities for GBM primarily involve maximal surgical resection, adjuvant radiotherapy, and systemic chemotherapy. However, the intrinsic heterogeneity of GBM poses a formidable obstacle to treatment efficacy. The immunosuppressive tumor microenvironment, coupled with the restrictive nature of the blood–brain barrier (BBB), significantly limits the intratumorally delivery of chemotherapeutic agents. The emergence of nanotechnology in the biomedical domain has been driven by the urgent need to develop more effective and targeted anticancer interventions. Optimizing therapeutic outcomes necessitates the concurrent application of multimodal strategies. This review emphasizes the Nano-Based Technology in GBM. Full article
(This article belongs to the Section Medicinal Chemistry)
Show Figures

Figure 1

23 pages, 3049 KB  
Article
Bioconversion of Date Waste into Bacterial Nanocellulose by a New Isolate Komagataeibacter sp. IS22 and Its Use as Carrier Support for Probiotics Delivery
by Islam Sayah, Ibtissem Chakroun, Claudio Gervasi, Davide Barreca, Giovanni Lanteri, Daniela Iannazzo, Consuelo Celesti, Antonello Santini, Sami Achour and Teresa Gervasi
Foods 2025, 14(16), 2853; https://doi.org/10.3390/foods14162853 - 18 Aug 2025
Viewed by 519
Abstract
Bacterial nanocellulose (BNC) has gained considerable interest over the last decade due to its unique properties and versatile applications. However, the low yield and the high production cost significantly limit its industrial scalability. The proposed study explores the isolation of new BNC producers [...] Read more.
Bacterial nanocellulose (BNC) has gained considerable interest over the last decade due to its unique properties and versatile applications. However, the low yield and the high production cost significantly limit its industrial scalability. The proposed study explores the isolation of new BNC producers from date palm sap and the use of date waste extract as a sustainable carbon source to improve BNC productivity. Results revealed three potential BNC producers identified as Komagataeibacter sp. IS20, Komagataeibacter sp. IS21, and Komagataeibacter sp. IS22 with production yield of 1.7 g/L, 0.8 g/L and 1.8 g/L, respectively, in Hestrin-Schramm (HS) medium. The biopolymer characterization indicated the presence of type I cellulose, a high thermal stability, and a highly dense network made of cellulose nanofibrils for all BNC samples. The isolate IS22, showing the highest productivity, was selected for an optimization procedure using a full factorial design with date waste extract as a carbon source. The BNC yield increased to 6.59 g/L using 4% date waste extract and 2% ethanol after 10 days of incubation compared to the standard media (1.8 g/L). Two probiotic strains, including Bacillus subtilis (BS), and Lactobacillus plantarum (LP) were successfully encapsulated into BNC matrix through a co-culture approach. The BNC-LP and BNC-BS composites showed antibacterial activity against Pseudomonas aeruginosa. BNC–probiotic composites have emerged as a promising strategy for the effective delivery of viable probiotics in a wide range of applications. Overall, this study supports the use of date waste extract as a sustainable carbon source to enhance BNC productivity and reduce the environmental footprint using a high-yielding producer (IS22). Furthermore, the produced BNC demonstrated promising potential as an efficient carrier matrix for probiotic delivery. Full article
(This article belongs to the Section Food Biotechnology)
Show Figures

Figure 1

8 pages, 275 KB  
Article
Sex Differences in Wheezing During the First Three Years of Life After Delivery via Caesarean Section
by Evangelia Papathoma, Theodore Dassios, Maria Triga, Sotirios Fouzas and Gabriel Dimitriou
Children 2025, 12(8), 1071; https://doi.org/10.3390/children12081071 - 14 Aug 2025
Viewed by 402
Abstract
Background: Emerging evidence suggests that delivery by caesarean section predisposes to wheezing in early childhood, but the effect may differ between boys and girls. Such sex-specific differences remain insufficiently explored to date, particularly considering the wide range of perinatal and antenatal confounding factors. [...] Read more.
Background: Emerging evidence suggests that delivery by caesarean section predisposes to wheezing in early childhood, but the effect may differ between boys and girls. Such sex-specific differences remain insufficiently explored to date, particularly considering the wide range of perinatal and antenatal confounding factors. In this study, we aimed to investigate sex-specific differences in the association between delivery by caesarean section and preschool wheezing. Methods: This is a secondary analysis of a population of 470 children (53% boys), born and cared for between August 2009 and March 2011 at the maternity services of the University Hospital of Patras, Greece. Participants were followed up regularly until the age of 36 months. Wheezing was defined as at least one episode of doctor-diagnosed wheezing per year during the surveillance period of three years. Multivariable regression models were used to explore possible associations and adjust for confounders. Results: The rate of caesarean section was 51% (N = 240). Wheezing was reported in 144 (31%) of the children. Following delivery by caesarean section, 52 of 137 (38%) of the boys and 33 of 103 (32%) of the girls developed wheezing. In the whole cohort, development of wheezing was significantly associated with male sex [odds ratio: 1.83 (95% CI: 1.22–2.75), adjusted p = 0.004], but not with caesarean section or gestational age. In girls, the development of wheezing was significantly associated with caesarean section [odds ratio: 2.48 (95% CI: 1.28–4.83), adjusted p = 0.007]. In boys, the development of wheezing was not significantly associated with delivery by caesarean section. Conclusions: Girls born by caesarean section developed wheezing more frequently than their vaginally born counterparts during the first three years of life. Although male sex proved an overall predisposing factor to preschool wheezing, boys born by caesarean section were not diagnosed with wheezing more frequently than those delivered vaginally. Full article
(This article belongs to the Section Pediatric Neonatology)
Show Figures

Figure 1

17 pages, 1594 KB  
Article
Isolation, Identification, and Virulence Properties of Enterobacter bugandensis Pathogen from Big-Belly Seahorse Hippocampus abdominalis
by Haibin Ye, Chenhao Teng, Yueqi Yang, Yiyao Liu, Li Li, Ying Fan, Youhong Wang, Jing Diao, Lingling Yu, Chunlei Gai and Haipeng Cao
Fishes 2025, 10(8), 411; https://doi.org/10.3390/fishes10080411 - 14 Aug 2025
Viewed by 334
Abstract
Nowadays, members of the genus Enterobacter have been documented as human and aquaculture pathogens. To date, no reports have described Enterobacter bugandensis infecting Hippocampus abdominalis. In the present study, an isolate of E. bugandensis, designated H4, was identified as a causative pathogen [...] Read more.
Nowadays, members of the genus Enterobacter have been documented as human and aquaculture pathogens. To date, no reports have described Enterobacter bugandensis infecting Hippocampus abdominalis. In the present study, an isolate of E. bugandensis, designated H4, was identified as a causative pathogen in cultured H. abdominalis following Koch’s postulate, and its virulence properties were further described. The isolate’s genome consisted of a single circular chromosome and harbored several virulence and resistance genes, including, but not limited to, csgG, acrB, hcp, gndA, galF, rpoS, fur, rcsB, and phoP involved in adherence, antimicrobial activity, effector delivery systems, immune modulation, and regulation, as well as baeR, blaACT-49, ramA, hns, ftsI, acrA, gyrA, fabI, crp, oqxB, parE, gyrB, phoP, rpoB, tuf, ptsI, and fosA2 functioning against aminoglycoside, cephamycin, disinfecting agent and antiseptic, fluoroquinolone, macrolide, peptide, and other antimicrobials. Additionally, the isolate exhibited multiple resistance to cephalosporins, penicillins, and tetracyclines and demonstrated a median lethal dose (LD50) of 4.47 × 105 CFU/mL in H. abdominalis. To our knowledge, this is the first study to describe E. bugandensis infecting H. abdominalis. These findings highlight the zoonotic potential of E. bugandensis and underscore the need for targeted health management in seahorse farming. Full article
Show Figures

Figure 1

20 pages, 1650 KB  
Review
Maillard Reaction-Derived Carbon Nanodots: Food-Origin Nanomaterials with Emerging Functional and Biomedical Potential
by Gréta Törős and József Prokisch
Pharmaceutics 2025, 17(8), 1050; https://doi.org/10.3390/pharmaceutics17081050 - 13 Aug 2025
Viewed by 552
Abstract
The Maillard reaction (MR), a non-enzymatic interaction between reducing sugars and amino compounds, plays a pivotal role in developing the flavor, color, and aroma of thermally processed foods. Beyond its culinary relevance, the MR gives rise to a structurally diverse array of compounds, [...] Read more.
The Maillard reaction (MR), a non-enzymatic interaction between reducing sugars and amino compounds, plays a pivotal role in developing the flavor, color, and aroma of thermally processed foods. Beyond its culinary relevance, the MR gives rise to a structurally diverse array of compounds, including a novel class of fluorescent nanomaterials known as carbon nanodots (CNDs). These Maillard-derived CNDs, although primarily incidental in food systems, exhibit physicochemical characteristics—such as aqueous solubility, biocompatibility, and tunable fluorescence—that are similar to engineered CNDs currently explored in biomedical fields. While CNDs synthesized through hydrothermal or pyrolytic methods are well-documented for drug delivery and imaging applications, no studies to date have demonstrated the use of Maillard-derived CNDs specifically in drug delivery. This review examines the chemistry of the Maillard reaction, the formation mechanisms and characteristics of food-based CNDs, and their potential functional applications in food safety, bioactivity, and future biomedical use. Additionally, it critically evaluates the health implications of Maillard reaction products (MRPs), including both beneficial antioxidants and harmful by-products such as advanced glycation end-products (AGEs). This integrated perspective highlights the dual role of MR in food quality and human health, while identifying key research gaps needed to harness the full potential of food-origin nanomaterials. Full article
Show Figures

Figure 1

30 pages, 2414 KB  
Review
Melittin-Based Nanoparticles for Cancer Therapy: Mechanisms, Applications, and Future Perspectives
by Joe Rizkallah, Nicole Charbel, Abdallah Yassine, Amal El Masri, Chris Raffoul, Omar El Sardouk, Malak Ghezzawi, Therese Abou Nasr and Firas Kreidieh
Pharmaceutics 2025, 17(8), 1019; https://doi.org/10.3390/pharmaceutics17081019 - 6 Aug 2025
Viewed by 2140
Abstract
Melittin, a cytolytic peptide derived from honeybee venom, has demonstrated potent anticancer activity through mechanisms such as membrane disruption, apoptosis induction, and modulation of key signaling pathways. Melittin exerts its anticancer activity by interacting with key molecular targets, including downregulation of the PI3K/Akt [...] Read more.
Melittin, a cytolytic peptide derived from honeybee venom, has demonstrated potent anticancer activity through mechanisms such as membrane disruption, apoptosis induction, and modulation of key signaling pathways. Melittin exerts its anticancer activity by interacting with key molecular targets, including downregulation of the PI3K/Akt and NF-κB signaling pathways, and by inducing mitochondrial apoptosis through reactive oxygen species generation and cytochrome c release. However, its clinical application is hindered by its systemic and hemolytic toxicity, rapid degradation in plasma, poor pharmacokinetics, and immunogenicity, necessitating the development of targeted delivery strategies to enable safe and effective treatment. Nanoparticle-based delivery systems have emerged as a promising strategy for overcoming these challenges, offering improved tumor targeting, reduced off-target effects, and enhanced stability. This review provides a comprehensive overview of the mechanisms through which melittin exerts its anticancer effects and evaluates the development of various melittin-loaded nanocarriers, including liposomes, polymeric nanoparticles, dendrimers, micelles, and inorganic systems. It also summarizes the preclinical evidence for melittin nanotherapy across a wide range of cancer types, highlighting both its cytotoxic and immunomodulatory effects. The potential of melittin nanoparticles to overcome multidrug resistance and synergize with chemotherapy, immunotherapy, photothermal therapy, and radiotherapy is discussed. Despite promising in vitro and in vivo findings, its clinical translation remains limited. Key barriers include toxicity, manufacturing scalability, regulatory approval, and the need for more extensive in vivo validation. A key future direction is the application of computational tools, such as physiologically based pharmacokinetic modeling and artificial-intelligence-based modeling, to streamline development and guide its clinical translation. Addressing these challenges through focused research and interdisciplinary collaboration will be essential to realizing the full therapeutic potential of melittin-based nanomedicines in oncology. Overall, this review synthesizes the findings from over 100 peer-reviewed studies published between 2008 and 2025, providing an up-to-date assessment of melittin-based nanomedicine strategies across diverse cancer types. Full article
(This article belongs to the Special Issue Development of Novel Tumor-Targeting Nanoparticles, 2nd Edition)
Show Figures

Figure 1

18 pages, 1812 KB  
Review
Nanocarriers for Medical Ozone Delivery: A New Therapeutic Strategy
by Manuela Malatesta and Flavia Carton
Nanomaterials 2025, 15(15), 1188; https://doi.org/10.3390/nano15151188 - 3 Aug 2025
Viewed by 537
Abstract
Ozone (O3) occurs in nature as a chemical compound made of three oxygen atoms. It is an unstable, highly oxidative gas that rapidly decomposes into oxygen. The therapeutic use of O3 dates back to the beginning of the 20th century [...] Read more.
Ozone (O3) occurs in nature as a chemical compound made of three oxygen atoms. It is an unstable, highly oxidative gas that rapidly decomposes into oxygen. The therapeutic use of O3 dates back to the beginning of the 20th century and is currently based on the application of low doses, inducing a moderate oxidative stress that stimulates the antioxidant cellular defenses without causing cell damage. Low O3 doses also induce anti-inflammatory and regenerative effects, and their anticancer potential is under investigation. In addition, the oxidative properties of O3 make it an excellent antibacterial, antimycotic, and antiviral agent. Thanks to these properties, O3 is currently widely used in several medical fields. However, its chemical instability represents an application limit, and ozonated oil is the only stabilized form of medical O3. In recent years, novel O3 formulations have been proposed for their sustained and more efficient administration, based on nanotechnology. This review offers an overview of the nanocarriers designed for the delivery of medical O3, and of their therapeutic applications. The reviewed articles demonstrate that research is active and productive, though it is a rather new entry in the nanotechnological field. Liposomes, nanobubbles, nanoconstructed hydrogels, polymeric nanoparticles, and niosomes were designed to deliver O3 and have been proven to exert antiseptic, anticancer, and pro-regenerative effects when administered in vitro and in vivo. Improving the therapeutic administration of O3 through nanocarriers is a just-started challenge, and multiple prospects may be foreseen. Full article
(This article belongs to the Section Biology and Medicines)
Show Figures

Graphical abstract

10 pages, 669 KB  
Case Report
SARS-CoV-2 and HCoV IgG Antibodies in the Breast Milk of a Postpartum SARS-CoV-2 Patient Following Bamlanivimab Administration: A Case Report
by Guadalein Tanunliong, Christopher Condin, Ana Citlali Márquez, Susan Li, Nimrat Binning, Miriam Gibson, Brayden Griffiths, Alissa Wright, Deborah Money, Mel Krajden, Muhammad Morshed, Agatha N. Jassem, Gregory Haljan and Inna Sekirov
COVID 2025, 5(8), 123; https://doi.org/10.3390/covid5080123 - 1 Aug 2025
Viewed by 377
Abstract
Breast milk can provide passive immunity to infants, serving as a valuable source of maternal antibodies while remaining a non-invasive sample for investigating maternal immune responses. To date, no studies have evaluated SARS-CoV-2 and potentially cross-reactive HCoV antibodies in breast milk following bamlanivimab [...] Read more.
Breast milk can provide passive immunity to infants, serving as a valuable source of maternal antibodies while remaining a non-invasive sample for investigating maternal immune responses. To date, no studies have evaluated SARS-CoV-2 and potentially cross-reactive HCoV antibodies in breast milk following bamlanivimab administration. A 36-year-old postpartum female was PCR-positive for SARS-CoV-2 four days post-delivery. Bamlanivimab was administered intravenously two days later. Breast milk was collected before bamlanivimab infusion, daily for two weeks post-infusion, then weekly until 102 days post-infusion. Mother and infant sera were collected only at 102 days post-infusion. All milk and serum samples were tested for IgG antibodies against SARS-CoV-2 and HCoV. We observed two distinct SARS-CoV-2 antibody peaks at days 3 and 29 post-infusion, likely representing bamlanivimab transfer and the post-infection antibody response. Beta-HCoV antibodies showed two peaks at days 6 and 29, potentially representing backboosted beta-HCoV responses and/or antibody cross-reactivity with SARS-CoV-2. Infant seropositivity for SARS-CoV-2 102 days post-infusion may represent antibodies from passive transfer via breastfeeding or a subclinical infection. This case highlights the value of breast milk as a non-invasive and repeatable sample to help understand maternal immune responses post-infection, exogenous antibody infusion, and passive antibody transfer during breastfeeding, which can provide insights into maternal–infant health research. Full article
(This article belongs to the Section COVID Clinical Manifestations and Management)
Show Figures

Figure 1

15 pages, 704 KB  
Review
Optimizing Treatment Precision: Role of Adaptive Radiotherapy in Modern Anal Cancer Management
by David P. Horowitz, Yi-Fang Wang, Albert Lee and Lisa A. Kachnic
Cancers 2025, 17(15), 2478; https://doi.org/10.3390/cancers17152478 - 26 Jul 2025
Viewed by 732
Abstract
Anal cancer is a rare malignancy with rising incidence. Definitive treatment with radiation and concurrent chemotherapy represent the standard of care for patients with non-metastatic disease. Advances in radiation delivery through the use of intensity-modulated radiotherapy have significantly reduced the toxic effects of [...] Read more.
Anal cancer is a rare malignancy with rising incidence. Definitive treatment with radiation and concurrent chemotherapy represent the standard of care for patients with non-metastatic disease. Advances in radiation delivery through the use of intensity-modulated radiotherapy have significantly reduced the toxic effects of treatment. Adaptive radiotherapy (ART) has emerged as a strategy to further enhance treatment precision and individualize therapy in response to patient-specific changes during the course of chemoradiotherapy. The rationale for ART in anal cancer stems from the recognition that significant anatomic and tumor changes can occur throughout the 5–6-week treatment course, including tumor shrinkage, weight loss, and variable rectal/bladder filling. This review discusses the role of ART in contemporary anal cancer management. We overview the principles of ART, delineate the technical workflows (including both computed tomography (CT) and MR-guided approaches), and examine how adaptive techniques are applied in treatment planning and delivery. We also review the clinical evidence to date, including dosimetric studies and emerging clinical trial data on ART in anal cancer, particularly its impact on outcomes and toxicity. Full article
(This article belongs to the Section Cancer Therapy)
Show Figures

Figure 1

36 pages, 1354 KB  
Review
Flavonol Technology: From the Compounds’ Chemistry to Clinical Research
by Tomasz Przybylski, Joanna Czerniel, Jakub Dobrosielski and Maciej Stawny
Molecules 2025, 30(15), 3113; https://doi.org/10.3390/molecules30153113 - 25 Jul 2025
Viewed by 791
Abstract
Flavonols, representing a subclass of flavonoids, are an important group of polyphenols. Their activity is associated with a number of beneficial properties, including hepatoprotective, senolytic, neuroprotective, and anticancer properties. They are found abundantly in many fruits, vegetables, and plant products, but flavonols’ chemistry [...] Read more.
Flavonols, representing a subclass of flavonoids, are an important group of polyphenols. Their activity is associated with a number of beneficial properties, including hepatoprotective, senolytic, neuroprotective, and anticancer properties. They are found abundantly in many fruits, vegetables, and plant products, but flavonols’ chemistry and structural properties result in their low bioavailability in vivo. In recent years, more and more studies have emerged that aim to increase the therapeutic potential of compounds belonging to this group, including by developing innovative nanoformulations. The present work focuses on the various steps, such as chemical analysis of the compounds, preformulation studies using drug delivery systems, preclinical studies, and finally clinical trials. Each of these elements is important not only for the innovation and efficacy of the therapy but most importantly for the patient’s health. There are also a limited number of studies assessing the population concentration of flavonols in the blood; therefore, this review presents an up-to-date survey of the most recent developments, using the most important compounds from the flavonol group. Full article
Show Figures

Graphical abstract

20 pages, 1477 KB  
Review
CRISPR/Cas13-Based Anti-RNA Viral Approaches
by Xiaoying Tan, Juncong Li, Baolong Cui, Jingjing Wu, Karl Toischer, Gerd Hasenfuß and Xingbo Xu
Genes 2025, 16(8), 875; https://doi.org/10.3390/genes16080875 - 25 Jul 2025
Viewed by 1068
Abstract
RNA viruses pose significant threats to global health, causing diseases such as COVID-19, HIV/AIDS, influenza, and dengue. These viruses are characterized by high mutation rates, rapid evolution, and the ability to evade traditional antiviral therapies, making effective treatment and prevention particularly challenging. In [...] Read more.
RNA viruses pose significant threats to global health, causing diseases such as COVID-19, HIV/AIDS, influenza, and dengue. These viruses are characterized by high mutation rates, rapid evolution, and the ability to evade traditional antiviral therapies, making effective treatment and prevention particularly challenging. In recent years, CRISPR/Cas13 has emerged as a promising antiviral tool due to its ability to specifically target and degrade viral RNA. Unlike conventional antiviral strategies, Cas13 functions at the RNA level, providing a broad-spectrum and programmable approach to combating RNA viruses. Its flexibility allows for rapid adaptation of guide RNAs to counteract emerging viral variants, making it particularly suitable for highly diverse viruses such as SARS-CoV-2 and HIV. This review discusses up-to-date applications of Cas13 in targeting a wide range of RNA viruses, including SARS-CoV-2, HIV, dengue, influenza, and other RNA viruses, focusing on its therapeutic potential. Preclinical studies have demonstrated Cas13’s efficacy in degrading viral RNA and inhibiting replication, with applications spanning prophylactic interventions to post-infection treatments. However, challenges such as collateral cleavage, inefficient delivery, potential immunogenicity, and the development of an appropriate ethical framework must be addressed before clinical translation. Future research should focus on optimizing crRNA design, improving delivery systems, and conducting rigorous preclinical evaluations to enhance specificity, safety, and therapeutic efficacy. With continued advancements, Cas13 holds great promise as a revolutionary antiviral strategy, offering novel solutions to combat some of the world’s most persistent viral threats. Full article
(This article belongs to the Section RNA)
Show Figures

Figure 1

32 pages, 5175 KB  
Article
Scheduling and Routing of Device Maintenance for an Outdoor Air Quality Monitoring IoT
by Peng-Yeng Yin
Sustainability 2025, 17(14), 6522; https://doi.org/10.3390/su17146522 - 16 Jul 2025
Viewed by 366
Abstract
Air quality monitoring IoT is one of the approaches to achieving a sustainable future. However, the large area of IoT and the high number of monitoring microsites pose challenges for device maintenance to guarantee quality of service (QoS) in monitoring. This paper proposes [...] Read more.
Air quality monitoring IoT is one of the approaches to achieving a sustainable future. However, the large area of IoT and the high number of monitoring microsites pose challenges for device maintenance to guarantee quality of service (QoS) in monitoring. This paper proposes a novel maintenance programming model for a large-area IoT containing 1500 monitoring microsites. In contrast to classic device maintenance, the addressed programming scenario considers the division of appropriate microsites into batches, the determination of the batch maintenance date, vehicle routing for the delivery of maintenance services, and a set of hard constraints such as QoS in air quality monitoring, the maximum number of labor working hours, and an upper limit on the total CO2 emissions. Heuristics are proposed to generate the batches of microsites and the scheduled maintenance date for the batches. A genetic algorithm is designed to find the shortest routes by which to visit the batch microsites by a fleet of vehicles. Simulations are conducted based on government open data. The experimental results show that the maintenance and transportation costs yielded by the proposed model grow linearly with the number of microsites if the fleet size is also linearly related to the microsite number. The mean time between two consecutive cycles is around 17 days, which is generally sufficient for the preparation of the required maintenance materials and personnel. With the proposed method, the decision-maker can circumvent the difficulties in handling the hard constraints, and the allocation of maintenance resources, including budget, materials, and engineering personnel, is easier to manage. Full article
(This article belongs to the Section Sustainable Engineering and Science)
Show Figures

Figure 1

19 pages, 2622 KB  
Article
Three-Compartment Pharmacokinetics of Inhaled and Injected Sinapine Thiocyanate Manifest Prolonged Retention and Its Therapeutics in Acute Lung Injury
by Zixin Li, Caifen Wang, Huipeng Xu, Qian Wu, Ningning Peng, Lu Zhang, Hui Wang, Li Wu, Zegeng Li, Qinjun Yang and Jiwen Zhang
Pharmaceutics 2025, 17(7), 909; https://doi.org/10.3390/pharmaceutics17070909 - 14 Jul 2025
Viewed by 535
Abstract
Background: Acute lung injury (ALI) is driven by inflammatory cascades and reactive oxygen species (ROS) generation, with the progression to severe cases markedly increasing mortality. Sinapine thiocyanate (ST), a bioactive natural compound isolated from Sinapis Semen Albae (SSA), demonstrates both anti-inflammatory and [...] Read more.
Background: Acute lung injury (ALI) is driven by inflammatory cascades and reactive oxygen species (ROS) generation, with the progression to severe cases markedly increasing mortality. Sinapine thiocyanate (ST), a bioactive natural compound isolated from Sinapis Semen Albae (SSA), demonstrates both anti-inflammatory and antioxidant pharmacological activities. However, no monotherapeutic formulation of ST has been developed to date. A dry powder inhaler (DPI) enables targeted pulmonary drug delivery with excellent stability profiles and high inhalation efficiency. Methods: ST was purified and prepared as inhalable dry powder particles via an antisolvent crystallization technique. The therapeutic mechanisms of ST against ALI were elucidated by network pharmacology and pharmacokinetic analyses, with the therapeutic efficacy of the ST DPI in ALI mitigation being validated using LPS-induced rat models. Results: The ST DPI showed ideal aerodynamic characteristics. Notably, ST exhibited a three-compartment (triexponential) pharmacokinetic profile following both intravenous tail vein injection and inhalation administration. Furthermore, the inhaled formulation displayed a prolonged systemic residence time, which confers therapeutic advantages for pulmonary disease management. Furthermore, the inhalation administration of ST demonstrated a 2.7-fold increase in AUC compared with oral gavage, with a corresponding enhancement in systemic exposure. The ST DPI formulation demonstrated significant therapeutic efficacy against ALI in rats by downregulating inflammatory cytokines and modulating oxidative stress levels, mechanistically achieved through the MAPK-mediated regulation of cellular apoptosis via a positive feedback loop. Conclusions: The unique triexponential plasma level profiles of an ST DPI provide a promising pharmacokinetics-based therapeutic strategy for ALI, leveraging its marked efficacy in attenuating inflammation, oxidative stress, and pulmonary injury. Full article
(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
Show Figures

Figure 1

14 pages, 242 KB  
Article
Current Practices and Recommendations for Children with Food Allergies and Feeding Behaviours: Insights from a Survey Among Australian Health Professionals
by Jennifer Kefford, Rebecca L. Packer, Merryn Netting, Elizabeth C. Ward and Jeanne Marshall
Children 2025, 12(7), 905; https://doi.org/10.3390/children12070905 - 9 Jul 2025
Viewed by 402
Abstract
Background: Children with food allergies can present with paediatric feeding disorder (PFD). However, access to coordinated multidisciplinary services to support these children in Australia is inconsistent. To date, the availability of services or the perceived care needs of Australian health professionals working [...] Read more.
Background: Children with food allergies can present with paediatric feeding disorder (PFD). However, access to coordinated multidisciplinary services to support these children in Australia is inconsistent. To date, the availability of services or the perceived care needs of Australian health professionals working with this population have not been formally explored. Methods: A web-based survey was distributed to health professionals in Australia. Quantitative demographic data were summarised using descriptive statistics, and open-ended responses were analysed using content analysis. Results: The final sample comprised 98 responses, with speech pathologists representing the largest professional group (n = 39; 40%). A majority (59%) worked in hospital-based services. Open-ended responses were coded utilising content analysis. Three categories were developed including (1) service delivery, (2) intervention, and (3) resources. Services were commonly impacted by long wait times, limited staff training, and inconsistencies between hospital and community care. Additionally, mental health support was frequently reported as insufficient. Conclusions: The findings from this study underscore the need for integrated services for children with food allergies and paediatric feeding disorder. Recommended areas for future research include exploring caregiver perspectives and the impact of food allergies and paediatric feeding disorder, and consideration of co-designed studies to inform service improvement initiatives. Full article
(This article belongs to the Section Pediatric Gastroenterology and Nutrition)
Back to TopTop